Universal Infectious Disease Assay Facilitated by CRISPR Mediated Depletion - Jumpcode Genomics

Jon Armstrong - Vice President, Research & Development at Jumpcode Genomics

  • Comparative performance of NGS platforms in a novel universal infectious disease assay
  • AVITI™ highly concordant in identifying all COVID samples tested regardless of Ct value
  • AVITI highly concordant in identifying all 49 non-human organisms tested

Download App Note

Contact Sales

By submitting this form you agree to our Privacy Policy and Terms and Conditions.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.